XTalks

JANUARY 31, 2024

Skye Bioscience is at the forefront of exploring the endocannabinoid system for drug development. Punit Dhillon, Chairman & CEO Skye Bioscience Punit brings two decades of experience as a leader and investor within the life sciences sector. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 116

Life Science Development Drugs Medicine 116

Drug Discovery World

APRIL 17, 2024

Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. A real revolution in life science development.”

Life Science 52

Life Science Clinical Research Marketing Development 52

Pharmaceutical Technology

NOVEMBER 8, 2022

Viatris has signed definitive agreements to acquire Oyster Point Pharma and Famy Life Sciences in a deal totalling nearly $700m-$750m in cash to establish an ophthalmology franchise. Oyster Point Pharma introduced Tyrvaya, a nasal spray approved by the Food and Drug Administration (FDA) to treat dry eye disease, in November last year.

Life Science 147

Life Science Sales Development Drugs 147

XTalks

MARCH 20, 2024

In this featured episode of Xtalks People in Life Sciences, Ayesha spoke with Ashish Jain, Senior Director of Clinical Safety and Pharmacovigilance (PV) at Curis , a pioneering biotech company specializing in cutting-edge cancer therapies. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 113

Life Science Development Drugs 113

Pharmaceutical Technology

JUNE 2, 2023

Anavex Life Sciences has secured new US intellectual property compositions patent for its ANAVEX 2-73 (blarcamesine). Anavex’s orally available drug candidate restores cellular homeostasis by targeting sigma-1 and M1 muscarinic receptors.

Life Science 130

Life Science Clinical Trials Clinical Trials Trials 130

Drug Channels

MARCH 18, 2024

Informa Connect’s Life Sciences Pricing & Contracting USA May 21-23, 2024 | New Orleans Drug Channels readers save 10% with code 24DRCH10* Whether your daily focus is on Medicaid, Government Pricing, 340B, Drug Price Transparency, Commercial Contracting or Chargebacks , we have you covered! All rights reserved.

Life Science 78

Life Science Regulation Drugs 78

Pharmaceutical Technology

JUNE 16, 2023

for an undisclosed sum, boosting its life science AI capabilities. The deal enables Verix to further improve its capacities to use AI to advance the brand growth of life science companies. Artificial intelligence (AI)-driven commercial optimisation platform provider Verix has purchased start-up.ai start-up.ai

Life Science 130

Life Science Engineer Branding Marketing 130

XTalks

FEBRUARY 14, 2023

The life science industry is constantly evolving, making it difficult to stay ahead of the curve. There’s no doubt that pharmaceutical and biotechnology organizations are utilizing innovative technology solutions across all sectors of drug development, research and development, supply chain, manufacturing and more.

Life Science 98

Life Science Clinical Trials Clinical Trials Development 98

XTalks

SEPTEMBER 6, 2023

David Young, founder and President R&D at Processa Pharmaceuticals, a clinical-stage pharmaceutical company developing personalized approaches to cancer treatments with a focus on next generation chemotherapy drugs with improved safety and efficacy. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 116

Life Science Drugs Development Research 116

Drug Discovery World

MARCH 15, 2024

Valneva Scotland scooped two prizes at Scotland’s Life Sciences Awards 2024, including the award for Innovation – Pharma Services And Drug Discovery, in a ceremony on 14 March in Glasgow. billion of contribution to the Scottish economy, the success of the life sciences sector is phenomenal.

Life Science 59

Life Science Vaccination Vaccine Clinical Trials 59

Pharmaceutical Technology

DECEMBER 14, 2022

GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. Wave will conduct all preclinical research for the programmes of both companies until investigational new drug (IND)-facilitating studies. .

Life Science 162

Life Science Development Gene Therapy Genetics 162

Bio Pharma Dive

JUNE 15, 2022

The fund, Third Rock’s sixth, comes amid a significant downturn in the biotech stock market, which has raised questions about the viability of young drug startups.

Life Science 316

Life Science Marketing Drugs 316

Drug Discovery World

OCTOBER 31, 2023

PwC has published a new report on the UK life sciences industry ‘The Life Sciences Future50’, highlighting companies that illustrate world-class science and innovation, including 32 in the therapeutics space. According to the report, the life science industry represents a £43.4 ($52.7)

Life Science 52

Life Science Drugs Research Development 52

XTalks

JANUARY 4, 2023

In this episode, Ayesha talked about some of the trends to look out for in the life sciences in 2023. Also hear about the issue of drug shortages and how pharma companies hope to tackle it in 2023. Read the full article here: 4 Life Sciences Trends for 2023.

Life Science 52

Life Science Gene Therapy Gene Pharma Companies 52

Drug Discovery World

MARCH 7, 2023

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce.

Life Science 98

Life Science DNA Clinical Development Development 98

Drug Discovery World

JULY 14, 2023

International investors are abandoning UK life sciences as excessive revenue clawback rates start to bite, according to the latest Life Sciences Competitiveness Indicators published by the government 1. While this drop is in part due to the pandemic related spike in life sciences investment in 2020 and 2021, the £7.1

Life Science 52

Life Science Branding Manufacturing Medicine 52

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

Drug Discovery World

SEPTEMBER 4, 2023

The Innovation Centre has enabled the rapid growth of the life sciences hub at Canary Wharf , providing opportunities for early-stage life science companies to collaborate and innovate. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World Image shows: Canary Wharf, London, UK.

Life Science 59

Life Science Gene Therapy Genome Genomics 59

XTalks

MAY 1, 2024

Robert Barrow Chief Executive Officer and Board Director MindMed Mr. Barrow is an accomplished pharmaceutical executive and clinical pharmacologist with over a decade of experience leading drug development programs in a variety of disease areas. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Production Development Drugs 52

Drug Discovery World

MAY 9, 2023

Cytiva and the life sciences business of Pall Corporation have completed their integration and are now united as one business under the Cytiva brand. In January 2023, the life sciences business of Pall separated from Pall Corporation. Pall’s biotech portfolio is now a product family in Cytiva’s bioprocess business.

Life Science 52

Life Science Branding Manufacturing Production 52

Drug Discovery World

FEBRUARY 6, 2024

Richard Torbett, Chief Executive of the ABPI said: “The UK’s life sciences industry can deliver the jobs and growth the country needs, while also transforming NHS health outcomes and boosting British scientific research. The post The ABPI sets out a manifesto for UK life sciences appeared first on Drug Discovery World (DDW).

Life Science 52

Life Science Medicine Vaccination Vaccine 52

Drug Discovery World

DECEMBER 4, 2023

The University of Glasgow and Kadans Science Partner, supported by Scottish Enterprise, have announced plans to construct a new Health Innovation Hub in Govan in Glasgow. It is hope that the new centre, which is due for completion in summer 2025, will set the stage for a thriving life sciences cluster in the area.

Life Science 52

Life Science Medicine Drugs Research 52

Drug Discovery World

MARCH 20, 2023

The resulting new Life Sciences and Diagnostics business will share the PerkinElmer name until a new name, brand and ticker symbol is unveiled in Q2 2023 pending shareholder approval. Within Life Sciences, the company is focused on supporting pharmaceutical and academic scientific advancement from the earliest stage of discovery.

Life Science 52

Life Science Branding Development Drugs 52

Drug Channels

MARCH 28, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights. All rights reserved.

Life Science 82

Life Science Marketing Production Development 82

XTalks

FEBRUARY 15, 2023

Bastiaan Driehuys, PhD Founder and Chief Technology Officer Polarean Imaging plc In this week’s Xtalks Life Science podcast episode, Ayesha and the editorial team spoke with Dr. Bastiaan Driehuys, Founder and Chief Technology Officer at Polarean Imaging plc. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 98

Life Science FDA Approval Drugs Production 98

Drug Discovery World

JULY 4, 2023

Vesalius Biocapital, a life sciences venture capital investor, has closed its fourth fund, Vesalius Biocapital IV, securing over €95 million of commitments. The company plans to invest in first and best-in-class European life science companies in drug development and digital health.

Life Science 52

Life Science Sales Development Medicine 52

Bio Pharma Dive

SEPTEMBER 12, 2023

Arialys Therapeutics launched Tuesday with $58 million in funding from a group of life sciences investors that includes Johnson & Johnson’s venture arm.

Life Science 299

Life Science Drugs 299

XTalks

AUGUST 23, 2023

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Williams about BriaCell’s novel cell therapies for cancer and what the future of immunotherapy and personalized treatments may look like.

Life Science 98

Life Science Clinical Trials Clinical Trials FDA Approval 98

Drug Discovery World

MARCH 14, 2023

Life sciences membership organisation OBN (UK) will be holding in-person event BioTrinity 2023 in London on April 25-26. The conference will feature two tracks: ‘Scientific’, showcasing innovation across eight core therapy areas, and ‘Life Sciences Business & Investment’.

Life Science 52

Life Science Gene Therapy Gene Drugs 52

Bio Pharma Dive

FEBRUARY 6, 2024

The life sciences investor has backed a number of startups working on technologies for delivering and manufacturing cell and gene medicines.

Drug Delivery 208

Drug Delivery Life Science Gene Manufacturing 208

Drug Discovery World

MARCH 16, 2023

There was some good news for the UK life sciences sector in the government’s Spring Budget, but did it go far enough? It will target UK taxpayer support to enable life science entrepreneurs to crowd in further private investment allowing them to grow and accelerate innovation in the UK.”

Life Science 97

Life Science Regulation Medicine Research 97

Drug Discovery World

FEBRUARY 10, 2023

A science-centric network for women in senior positions across industry and academia has launched in Denmark to strengthen the life sciences industry and promote talent, diversity and inclusiveness. Women in Life Science Denmark (WiLD) has received support from the Novo Nordisk Foundation, contributing €56,000 ($60,293) over the next three years.

Life Science 52

Life Science Drugs 52

Drug Discovery World

MAY 10, 2023

PerkinElmer’s Life Sciences division has revealed its new name and branding. Revvity has now officially launched as a science-based solutions company. The post PerkinElmer Life Sciences division becomes Revvity appeared first on Drug Discovery World (DDW).

Life Science 52

Life Science Reagent Genome Genomics 52

pharmaphorum

MARCH 8, 2022

How did you get into life sciences? Our products are used primarily in the fight against cancer – to aid drug discovery – while also ensuring patients and laboratory workers are safe. Why is it important to encourage girls and young women to pursue life sciences roles? What has your career path been?

Life Science 98

Life Science Engineer Scientist Doctors 98

Drug Discovery World

AUGUST 4, 2023

CRADL’s first Seattle facility opened in 2021, in response to the city’s growing position as a key life sciences hub with significant start-up and entrepreneurial growth. In October, CRADL Philadelphia will open in uCity Square to support Philadelphia’s growth as a life sciences biohub.

Life Science 52

Life Science Gene Therapy Gene Editing In-Vivo 52

XTalks

JANUARY 10, 2024

Dr. Kaplin transitioned into industry by joining MIRA Pharmaceuticals to help lead drug development in the space. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.

Life Science 52

Life Science Development Drugs Medicine 52

Drug Discovery World

JUNE 14, 2023

Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia. AI is already powering drug discovery and development 82% of respondents that use digital pathology have begun to implement AI.

Life Science 52

Life Science Research Drugs Containment 52